India's Drug Exporters Await Court Ruling On New Bar-Code Requirement
This article was originally published in PharmAsia News
India's drug exporters, who face a year-end deadline for adding bar-codes to their packaging, await a possible Madras High Court decision before then on a challenge to the edict intended to provide a traceable system to detect fake "Made In India" drugs actually made in China.
You may also be interested in...
FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.
Richard Pazdur, FDA's oncology chief, reiterates the breakthrough therapy designation is for agency-sponsor communication and not an investor tool.